Nanobiotix Appoints New CFO Amid Late-Stage Clinical Transition
Nanobiotix (NASDAQ: NANO) announced Arnd Christ as new CFO, succeeding a five-year incumbent. The transition coincides with Phase III data readouts and commercial launch preparation for its lead oncology asset.
51CFO view：New CFOs at NASDAQ-listed biotechs must file Form 8-K within 4 business days and immediately master ASC 606 revenue timing, cross-border royalty tax allocations, and FDA-approved inventory capitalization — requiring proven U.S. SOX 302/404 certification experience.
Nanobiotix (NASDAQ: NANO) announced Arnd Christ as new CFO, succeeding a five-year incumbent. The transition coincides with Phase III data readouts and commercial launch preparation for its lead oncology asset.
Source：Google News · CFO 任命
Why this matters to your CFO search
Where this touches your finance hire
Every listing event changes what you need from a CFO. Start from the step you are actually at.
How is a US-listed CFO paid?
Base, equity incentive and listing-milestone bonus: structure and ranges.
Read →
What kind of CFO does a US IPO need?
S-1 / F-1 filing, US GAAP conversion, roadshow — the hard requirements.
Read →
Who runs finance through a SPAC merger?
De-SPAC files F-1 / 424(b); merger audit and disclosure cadence differ.
Read →